BioNTech SE BNTX
NASDAQ BNTX
$98.57 -0.51 (-0.51%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) EV to EBIT (2021 - 2023)

Updated

BioNTech SE's (BNTX) EV to EBIT came in at 23.24 for Q4 2023, compared with 1.64 a year earlier and up 428.1% from the prior quarter.

Analysis

BioNTech SE (BNTX) EV to EBIT (2021 - 2023) Analysis & Trends

For FY2023, BioNTech SE's EV to EBIT stood at 22.99.

  • In prior years, BioNTech SE's EV to EBIT was 1.70 in FY2022 (-51.7%) and 3.53 in FY2021.
  • The Q4 2023 figure stands as the highest quarterly EV to EBIT in data going back to Q1 2021.
  • On a year-over-year basis, EV to EBIT increased in three of the last seven quarters, with growth averaging 5.1%.
  • According to Business Quant data, EV to EBIT for the three prior quarters was 4.40 (Q3 2023), 2.30 (Q2 2023) and 2.01 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 BioNTech SE 25.06 Bn -34.31 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 23.24
Sep 30, 2023 4.40
Jun 30, 2023 2.30
Mar 31, 2023 2.01
Dec 31, 2022 1.64
Sep 30, 2022 1.27
Jun 30, 2022 1.44
Mar 31, 2022 1.65
Dec 31, 2021 3.43
Sep 30, 2021 4.76
Jun 30, 2021 7.23
Mar 31, 2021 12.38
API Access

BioNTech SE EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BNTX&period=max&api_key=YOUR_API_KEY